Efficacy of Nutritional Therapy for Patients With Cirrhosis and Minimal Hepatic Encephalopathy in a Randomized Trial  Sudhir Maharshi, Barjesh Chander Sharma, Sanjeev Sachdeva, Siddharth Srivastava, Praveen Sharma  Clinical Gastroenterology and Hepatology  Volume 14, Issue 3, Pages 454-460.e3 (March 2016) DOI: 10.1016/j.cgh.2015.09.028 Copyright © 2016 AGA Institute Terms and Conditions

Figure 1 Screening, randomization and follow-up evaluation of study patients. DST, digit symbol test; FCT-A, figure connection test A; FCT-B, figure connection test B; LTT, line tracing test; NCT-A, number connection test A; NCT-B, number connection test B; SDT, serial dotting test. Clinical Gastroenterology and Hepatology 2016 14, 454-460.e3DOI: (10.1016/j.cgh.2015.09.028) Copyright © 2016 AGA Institute Terms and Conditions

Figure 2 Sickness impact profile score (mean value) in both groups at baseline and at 6 months. P > .05 for all categories at baseline in both groups. A, alertness; AB, ambulation; BCM, body care and movements; C, communication; E, eating; EB, emotional behavior; HM, home management; M, mobility; NNT0, no nutritional therapy group at baseline; NNT6, no nutritional therapy group at 6 months; NT0, nutritional therapy group at baseline; NT6, nutritional therapy group at 6 months; RP, recreation and pastime; SI, social interaction; SR, sleep and rest; W, work; Psych, psychosocial; Physi, physical. Clinical Gastroenterology and Hepatology 2016 14, 454-460.e3DOI: (10.1016/j.cgh.2015.09.028) Copyright © 2016 AGA Institute Terms and Conditions